Daniel Faga
Interim CEO at AnaptysBio Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: AnaptysBio Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AnaptysBio Inc. June 12, 202497.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | AnaptysBio Inc. | Open-market sale | −510 | $56.61 | $28,871 |
| Mar 27, 2026 | AnaptysBio Inc. | Open-market sale | −2,570 | $57.91 | $148,829 |
| Mar 27, 2026 | AnaptysBio Inc. | Open-market sale | −3,662 | $58.62 | $214,666 |
| Mar 27, 2026 | AnaptysBio Inc. | Open-market sale | −490 | $59.62 | $29,214 |
| Mar 27, 2026 | AnaptysBio Inc. | Open-market sale | −550 | $60.63 | $33,347 |
| Mar 27, 2026 | AnaptysBio Inc. | Open-market sale | −1,012 | $62.15 | $62,896 |
| Mar 27, 2026 | AnaptysBio Inc. | Open-market sale | −2,592 | $63.35 | $164,203 |
| Mar 27, 2026 | AnaptysBio Inc. | Open-market sale | −3,155 | $64.19 | $202,519 |
| Mar 27, 2026 | AnaptysBio Inc. | Open-market sale | −3,038 | $65.20 | $198,078 |
| Mar 27, 2026 | AnaptysBio Inc. | Open-market sale | −100 | $65.99 | $6,599 |
| Mar 25, 2026 | AnaptysBio Inc. | Grant or award | +34,300 | — | — |
| Jan 8, 2026 | AnaptysBio Inc. | Open-market sale | −14,281 | $44.71 | $638,504 |
| Jan 7, 2026 | AnaptysBio Inc. | Option exercise | +26,838 | — | — |
| Jan 7, 2026 | AnaptysBio Inc. | Open-market sale | −9,202 | $45.11 | $415,102 |
| Jan 6, 2026 | AnaptysBio Inc. | Option exercise | +17,850 | — | — |
Questions about Daniel Faga
What boards is Daniel Faga on?
Daniel Faga sits on the boards of AnaptysBio Inc. and First Tracks Biotherapeutics Inc.
What company is Daniel Faga the CEO of?
Daniel Faga is Interim CEO of AnaptysBio Inc. and Daniel Faga has been President, CEO of First Tracks Biotherapeutics Inc. since April 2026.
How long has Daniel Faga served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.